Belgium’s UCB inks global biotech deal with China’s Antengene [Advocacy Lab]

Fuente: Euroactiv
Lugar: Belgium
UCB’s licensing deal with China’s Antengene follows rising global demand for Chinese-developed drug candidates
Volver